IDiyas

For the Inventor, By the Inventor

Paris, France

Maurice Brollo

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 9.3

ph-index = 4

Forward Citations = 33(Granted Patents)


Location History:

  • Antony, FR (2015)
  • Paris, FR (2014 - 2023)

Company Filing History:

goldMedal10 out of 1,451 
 
Sanofi
 patents
silverMedal1 out of 377 
 
Aventis Pharma S.a.
 patents

Years Active: 2014-2023

Loading Chart...
Loading Chart...
11 patents (USPTO):
1. 11739100 - 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof (2023-08-29),
2. 11214541 - Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof (2022-01-04),
3. 11149031 - Substituted N-(3-fluoropropyl)-pyrrolidine compounds, processes for their preparation and therapeutic uses thereof (2021-10-19),
4. 10570090 - Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof (2020-02-25),
5. 10253043 - 2,3-dihydro-1H-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof (2019-04-09),
6. 9714221 - Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof (2017-07-25),
7. 9133168 - Pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors (2015-09-15),
8. 9126969 - Pyrazolylbenzimidazole derivatives, compositions containing them and use thereof (2015-09-08),
9. 8846670 - 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof (2014-09-30),
10. 8828997 - 2,3-dihydro-1H-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof (2014-09-09),
11. 8815853 - Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof (2014-08-26),

Title: The Innovative Contributions of Maurice Brollo

Introduction

Maurice Brollo is a notable inventor based in Paris, France, recognized for his significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, Brollo has made strides in developing novel compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents are the compounds 2,3-dihydro-1H-imidazo{1,2-a}pyrimidin-5-one and 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives. These compounds comprise a substituted morpholine and are prepared for pharmaceutical use, particularly as anticancer medications. The detailed formula includes various substituents and configurations, showcasing the complexity and innovation behind his work.

Career Highlights

Brollo has worked with prominent companies in the pharmaceutical industry, including Sanofi and Aventis Pharma S.A. His experience in these organizations has allowed him to contribute to the development of groundbreaking medicinal products.

Collaborations

Throughout his career, Brollo has collaborated with esteemed colleagues, including Bruno Filoche-Romme and Frank Halley. These partnerships have fostered an environment of innovation and creativity in the research and development of new pharmaceutical compounds.

Conclusion

Maurice Brollo's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations highlight his commitment to advancing medical science and improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…